← SynDRA
PD-166793
SynDRA canonical compound SYN0086838 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | MMP13 |
| Mechanism of action | Metalloproteinase inhibitor |
All known targets
Mechanisms of action (all sources)
- Collagenase inhibitor
- Metalloproteinase inhibitor
Cross-references
Synonyms
- PD 166793
- U855L3SOXD
- L-Valine, N-[(4'-bromo[1,1'-biphenyl]-4-yl)sulfonyl]-
- PD-166793-0000
- L-Valine, N-((4'-bromo(1,1'-biphenyl)-4-yl)sulfonyl)-
- UNII-U855L3SOXD
- orb1705564
- SCHEMBL4433724
- ((4'-bromo-[1,1'-biphenyl]-4-yl)sulfonyl)-L-valine
- BDBM12075
- GJOCABIDMCKCEG-INIZCTEOSA-N
- HMS3413F07
- HMS3677F07
- EX-A14360
- MFCD12912437
- alpha-arylsulfonylamino carboxylate 2S
- AKOS016004908
- MS-27114
- HY-107428
- CS-0028458
- E98781
- T20563
- N-(4'-Bromo[1,1'-biphenyl]-4-sulfonyl)-L-valine
- BRD-K60984070-001-01-0
Look up PD-166793 in the interactive SynDRA portal →